Sep 25, 2025 6:45 AM Eastern Daylight Time Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025 Share More than 45 abstracts, including five late-breaking presentations and recognition in Presidential Symposium, showcase impact of approved medicines and potential of next-generation pipeline NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) will highlight data across its extensive Oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2025, being held Oc ...